Cycle view
- Bloc
- Organization
- Theory
- Practical
- Others
- Credits
| Code | Details | Bloc | Organization | Theory | Practical | Others | Credits |
|---|---|---|---|---|---|---|---|
| PHAR0007-1 | Personal research work - [10h Supervision of internship, 100h Personal research] | B2 | Q1 | - | - | [+] | 15 |
Focus optional courses
- B2
- 15Cr
| Code | Details | Bloc | Organization | Theory | Practical | Others | Credits |
|---|---|---|---|---|---|---|---|
| MSTG0352-2 | Research internship abroad or in Belgium - [450h internship] | B2 | Q1 | - | - | [+] | 15 |
| MSTG0353-2 | Developpment cooperation internship abroad - [450h internship] | B2 | Q1 | - | - | [+] | 15 |
| MSTG4001-1 | Hospital internship abroad - [450h internship] | B2 | Q1 | - | - | [+] | 15 |
| MSTG9082-1 | Officinal internship abroad - [450h internship] | B2 | Q1 | - | - | [+] | 15 |
| Notice : Le stage est associé à un travail de recherche personnel devant être défendu publiquement. Ce rapport doit obligatoirement être rédigé en anglais lorsqu'il est associé à un stage de recherche. Concernant les autres types de stage, le rapport peut être rédigé en français, avec l'accord du promoteur, si le stage est effectué en milieu francophone. Sinon, l'anglais est de rigueur. | |||||||
| Code | Details | Bloc | Organization | Theory | Practical | Others | Credits |
|---|---|---|---|---|---|---|---|
| PHAR0344-3 | Medicines analysis | B1 | Q1 | 45 | 28 | - | 7 |
| PHAR0343-3 | Pharmaceutical technologies and biopharmacy (part I) | B1 | Q1 | 20 | 60 | - | 4 |
| PHAC0341-2 | Special pharmacology (Part I) | B1 | Q1 | 25 | - | - | 3 |
| TOXI0341-2 | Toxiocological chemistry, Part I | B1 | Q1 | 4 | |||
| Toxiocological chemistry | 25 | - | - | ||||
| Toxicological chemistry, supplement for pharmacy - [12h Seminar] | - | - | [+] | ||||
| BIOC0340-1 | Clinical Chemistry (Part I) - [12h Seminar] | B1 | Q1 | 22 | - | [+] | 4 |
| MBIO0002-1 | Pharmaceutical Microbiology | B1 | Q1 | 16 | - | - | 2 |
| PHAR2018-1 | Officinal pharmaceutical good practices - [6h Seminar] | B1 | Q1 | 10 | - | [+] | 2 |
| ECON0340-1 | Pharmacoeconomy | B1 | Q1 | 10 | - | - | 1 |
| PHAR0003-1
| Pharmaceutical tehcnologies and biopharmacy (part II) - [5h Seminar]
Corequisite
| B1 | Q2 | 25 | - | [+] | 4 |
| PHAR0347-3 | Practical work - Pharmaceutical technologies and Biopharmacy
Corequisite
| B1 | Q2 | - | 32 | - | 2 |
| PHAC0342-2 | Special pharmacology (Part II)
Corequisite
| B1 | Q2 | 20 | - | - | 2 |
| TOXI0342-2 | Clinical Toxicology and adverse drug events monitoring (Part II) - [12h Seminar]
Corequisite
| B1 | Q2 | 25 | - | [+] | 4 |
| BIOC0341-1 | Clinical chemistry (2nd part) - [12h Seminar]
Corequisite
| B1 | Q2 | 23 | - | [+] | 4 |
| PHAR0004-1 | Pharamcotherapy and pharmaceutical cares - [10h Seminar] | B1 | Q2 | 30 | - | [+] | 5 |
| SANT0005-1 | Therapeutic approach - [30h Séminaire Interdisciplinaire] | B1 | Q2 | - | - | [+] | 3 |
| LEGI0340-2 | Legislation and pharmaceutical ethics | B1 | Q2 | 30 | - | - | 4 |
| PHAR2219-1 | Integrated work 2 - [30h Learning based on problem-solv]
Corinne Charlier, Brigitte Evrard, Marianne Fillet, Pierre Francotte, Michel Frederich, Philippe Hubert, Anna Lechanteur, Allison Ledoux, Geneviève Philippe, Géraldine Piel, Anne-Catherine Servais, Vincent Seutin, Eric Ziemons
Corequisite
| B1 | Q2 | - | - | [+] | 3 |
| PHAR2020-1 | Integrated practical activities | B1 | Q2 | 2 | |||
| Integrated practical work | - | 40 | - | ||||
| Industrial visits - [25h Visit]
Corequisite
| - | - | [+] | ||||
| APPR0160-2 | Professional development Seminar - [30h Learning based on problem-solv]
Etienne Cavalier, Corinne Charlier, Alain Chaspierre, Raphaël Denooz, Brigitte Evrard, Marianne Fillet, Pierre Francotte, Michel Frederich, Philippe Hubert, Anna Lechanteur, Frédéric Lecomte, Anne-Laure Lenoir, Geneviève Philippe, Géraldine Piel, Anne-Catherine Servais, Eric Ziemons
Corequisite
| B2 | Q2 | - | - | [+] | 5 |
Compulsory Training |
|||||||
| PHAR0721-1 | Incorporation of pharmaceutical knowledge
Corinne Charlier, Raphaël Denooz, Brigitte Evrard, Marianne Fillet, Pierre Francotte, Michel Frederich, Julien Hanson, Frédéric Lecomte, Geneviève Philippe, Géraldine Piel, Anne-Catherine Servais, Vincent Seutin
Corequisite
| B2 | Q2 | - | 50 | - | 5 |
| MTFE0351-3 | Officinal Internship and Thesis | B2 | Q2 | 20 | |||
| Record of learning and participation to clinical research project - [100h Personal research] | - | - | [+] | ||||
| Officinal internship and Thesis - [6mois internship]
Prerequisite
Corequisite
| - | - | [+] | ||||
| Notice : Les étudiants doivent accomplir un stage officinal d'une durée légale de six mois (26 semaines), associé à la rédaction d'un dossier d'apprentissage (TFE). Ce stage comprend un stage d'initiation obligatoire de 2 semaines, durant l'été, à l'issue du cycle de bachelier. Pour les étudiants ayant acquis au minimum 45 crédits du bloc 1 du master, le stage officinal peut se poursuivre pendant les vacances d'été précédant l'entrée au bloc 2 du master (maximum 8 semaines). Le solde de semaines (minimum 16 semaines) est presté dans le cadre du bloc 2 du master (2e quadrimestre). |
|||||||